An observational study in Gaucher Disease, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Month and older. Per ClinicalTrials.gov, last updated 2026-09-28.
Sponsored by Assiut University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This cross-sectional study aims to evaluate the nutritional status of patients with Gaucher disease attending Assiut University Children's Hospital using anthropometric measurements and body composition analysis.
Gaucher disease is a lysosomal storage disorder that may affect growth and nutritional status, particularly in children. This observational study will include patients with confirmed Gaucher disease (types 1, 2, and 3) who attend follow-up visits at Assiut University Children's Hospital.
Nutritional status will be assessed by detailed dietary history, anthropometric measurements (weight, height, BMI, mid-arm circumference), and body composition analysis using bioelectrical impedance analysis (BIA).
177 studies on the registry are indexed under Gaucher Disease; 41 are open to participants now.
This study's planned enrollment of 84 is above the median of 63 across 67 observational studies indexed under Gaucher Disease.
Browse Gaucher Disease studies →Assiut University is the lead sponsor of 5,088 studies on the registry; 2,185 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with confirmed Gaucher disease attending Assiut University Children's Hospital for follow-up visits.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with confirmed Gaucher disease (types 1, 2, and 3) who will undergo nutritional assessment including anthropometry and body composition analysis.
Prevalence of underweight
Proportion of patients with weight-for-age below -2 standard deviations according to WHO growth charts.
Time frame: Baseline
Prevalence of stunting
Proportion of patients with height-for-age below -2 standard deviations according to WHO growth charts.
Time frame: Baseline
Mean body mass index
Mean body mass index (BMI) in kg/m².
Time frame: Baseline
Mean mid-arm circumference
Mean mid-upper arm circumference in centimeters.
Time frame: Baseline
Mean fat mass percentage
Mean fat mass percentage measured by bioelectrical impedance analysis (BIA).
Time frame: Baseline
Mean lean body mass
Mean lean body mass measured by bioelectrical impedance analysis (BIA).
Time frame: Baseline
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.